Treatment of Hypotension
For acute hypotension, immediately administer epinephrine (0.2-0.5 mL of 1:1000 dilution intramuscularly) if anaphylaxis is suspected, or phenylephrine/norepinephrine for non-anaphylactic causes, while simultaneously addressing the underlying mechanism (vasodilation, hypovolemia, bradycardia, or low cardiac output). 1, 2, 3
Immediate Assessment and Intervention
The first critical step is determining the underlying cause through rapid physiological assessment:
Identify the Mechanism
Hypotension results from four primary mechanisms that require different treatments 3:
- Vasodilation: Treat with vasopressors (phenylephrine, norepinephrine)
- Hypovolemia: Treat with fluid resuscitation (crystalloids 10-30 mL/kg)
- Bradycardia: Treat with atropine or glycopyrrolate
- Low cardiac output: Treat with inotropes (dobutamine, epinephrine)
Context-Specific Immediate Management
- Epinephrine 0.2-0.5 mL (1:1000) IM into deltoid or anterolateral thigh every 5 minutes as needed
- Place patient recumbent with legs elevated
- Establish IV access and administer normal saline 1-2 L rapidly (adults) or 30 mL/kg (children)
- Administer oxygen 6-8 L/min
- If hypotension persists after multiple epinephrine doses, consider epinephrine infusion (1 mg in 250 mL D5W at 1-4 mcg/min)
In obstructive hypertrophic cardiomyopathy 2:
- Use phenylephrine (pure vasoconstrictor) for acute hypotension
- AVOID dopamine, dobutamine, norepinephrine, and other positive inotropes - these are potentially harmful as they worsen outflow obstruction
- Administer IV fluids first before vasopressors
In perioperative/postoperative settings 5, 3:
- Perform passive leg raise (PLR) test to assess fluid responsiveness
- If PLR improves blood pressure (88% sensitivity): give fluid bolus
- If PLR does not improve blood pressure: use vasopressors or inotropes, not fluids
- For hypotension with tachycardia: phenylephrine is preferred (causes reflex bradycardia)
- Target mean arterial pressure (MAP) ≥65 mmHg, adjusted upward if increased compartment pressures exist (e.g., add 15 mmHg to target if intraabdominal pressure is 15 mmHg)
Orthostatic Hypotension: Stepwise Management
For chronic orthostatic hypotension, follow this sequential approach 6, 7, 8, 9:
Step 1: Remove Offending Agents
- Discontinue or reduce antihypertensives, diuretics, vasodilators, alpha-blockers (tamsulosin), tricyclic antidepressants, trazodone, sildenafil, and carvedilol 10, 11
- Switch necessary medications to bedtime dosing
Step 2: Non-Pharmacological Measures (First-Line)
- Increase salt intake to 10 g/day and fluid intake to 2-3 L/day 6
- Rapid cool water ingestion (500 mL) acutely raises blood pressure 6, 10
- Sleep with head of bed elevated 10° to prevent nocturnal polyuria 6
- Abdominal binders and compression stockings reduce venous pooling 6
- Physical counterpressure maneuvers (leg crossing, squatting) for patients with warning symptoms 6
- Avoid large carbohydrate-rich meals; use acarbose for postprandial hypotension 10
Step 3: Pharmacological Treatment (If Non-Pharmacological Fails)
For neurogenic orthostatic hypotension 6, 12, 11, 13:
First-line agents:
- Midodrine 5-20 mg three times daily (alpha-agonist; FDA-approved) - increases blood pressure in supine and upright posture 6, 11, 13
- Droxidopa (norepinephrine prodrug; FDA-approved 2014) - well-tolerated and effective 12, 11, 13
Second-line agents:
- Fludrocortisone 0.1-0.3 mg once daily (mineralocorticoid) - expands fluid volume 6, 11
- Pyridostigmine (facilitates cholinergic neurotransmission in autonomic ganglia) - useful in combination therapy 10, 11
- Atomoxetine (norepinephrine reuptake inhibitor) - emerging evidence, especially for central autonomic failure 10, 11
Additional options:
- Desmopressin for nocturnal polyuria
- Octreotide for post-prandial hypotension 6
- Erythropoietin if anemia present
Step 4: Combination Therapy
If monotherapy fails, combine agents with different mechanisms (e.g., midodrine + fludrocortisone) 11, 13
Critical Pitfalls to Avoid
Do NOT use beta-blockers for vasovagal syncope - multiple long-term controlled trials show no benefit 7
In hypertrophic cardiomyopathy with hypotension, NEVER use positive inotropes (dopamine, dobutamine) - they worsen obstruction; use phenylephrine only 2
Do NOT assume all hypotension requires fluid - only ~50% of postoperative hypotensive patients respond to fluids 5; use PLR test to guide therapy
Avoid aggressive fluid resuscitation without assessing fluid responsiveness - this causes fluid overload in 46% of patients 5
In patients with supine hypertension and orthostatic hypotension (common in neurogenic OH), use short-acting antihypertensives at bedtime only 10
Monitor for supine hypertension when treating orthostatic hypotension pharmacologically - a common adverse effect requiring dose adjustment 13
Special Populations
Heart failure with reduced ejection fraction and low blood pressure 14:
- Asymptomatic low blood pressure should NOT prompt GDMT reduction
- Only reduce GDMT if systolic BP <80 mmHg with symptoms or organ hypoperfusion
- SGLT2 inhibitors and MRAs have minimal BP effects and may actually increase BP in low BP patients
- Prioritize maintaining GDMT over treating asymptomatic low numbers
Pediatric critically ill patients 15:
- Target MAP at least 10th percentile for age
- Use balanced crystalloids for initial resuscitation
- Norepinephrine is first-line for distributive shock
- Early multimodal assessment including point-of-care ultrasound